Latest Articles & Resources FEATURED Why AAV Programs Fail to Scale and What Academics Need to Do Differently Read More » Why AAV Programs Fail to Scale and What Academics Need to Do Differently Read More » LATEST NEWS + INTERVIEWS Lonza Launches Media Development Lab in Singapore to Support Bioprocessing Scale-Up SHINE Technologies Signs Lu-177 Supply Agreement with C-Ray for China Market Made Scientific Partners with NJIT to Launch Bioprocessing Courses for CGT Workforce FUJIFILM Biotechnologies Wins Most Innovative CDMO Award at 2026 CDMO Leadership Awards Lifecore Biomedical Signs Two CDMO Agreements with Existing U.S. Customer Tevogen Advances CRO Evaluation Targeting $20M+ Revenue Growth Samsung Biologics Wins Sustainability Leadership Award at 2026 CDMO Leadership Awards Olon Unveils 2026 Global Expansion Plan Across US, India, Italy, and France Hybrid Synthesis is Redefining Peptide Manufacturing BSP Announces €700 Million Expansion Plan for 2026–2030 at DCAT Forum Experic Partners with Flurry Powders to Advance Spray-Dried Drug Development LOTTE Biologics Wins Best New or Relaunched CDMO at 2026 CDMO Leadership Awards Piramal Pharma Solutions Installs Korsch X3 Tablet Press at UK CDMO Site Triera Biosciences Launches CRO Services for Aptamer Discovery and Biosensor Development What Cell Therapy Biotechs Get Wrong When Selecting a CDMO Aragen Life Sciences Signs MoU with Thermo Fisher to Advance Biologics Manufacturing UCB Selects Georgia for 460,000 sq. ft. Biologics Manufacturing Facility SK pharmteco Partners with Prozomix to Access 6,000 Biocatalysts for API Manufacturing Applied StemCell and Cellipont Bioservices Partner to Advance iPSC Cell Therapy Manufacturing The Iran conflict affects less than 1% of U.S. pharmaceutical supply Rentschler Biopharma Celebrates Milford Site Growth Following U.S. Expansion PODCAST INTERVIEWS Hybrid Synthesis is Redefining Peptide Manufacturing The Case for Strategic CDMO Partnerships Over Multi-Sourcing CDMO Consolidation “Inevitable” Without Business Model Shift, Warns Cell Therapy CEO
